Chegini N, Safa A R
Department of Obstetrics & Gynecology, School of Medicine, University of Louisville, KY 40292.
Cancer Lett. 1987 Nov;37(3):327-36. doi: 10.1016/0304-3835(87)90118-2.
The effect of mitoxantrone (DHAQ) on [3H]thymidine and [3H]uridine incorporation by exponentially growing MDA-MB-231, a human breast tumor cell line has been studied. The results have indicated that DHAQ was more effective in inhibiting [3H]thymidine than [3H]uridine incorporation in a concentration dependent manner. Following drug treatment at 20 ng/ml concentration, 50% inhibition of growth and [3H]thymidine incorporation were noted, whereas [3H]uridine incorporation was only inhibited by about 12%. At 2000 ng/ml of DHAQ the inhibition of cell growth, [3H]thymidine and [3H]uridine incorporations were 78%, 95% and 62%, respectively. Nuclear-associated radioactivity detected at light and electron microscope autoradiographic levels after [3H]thymidine and [3H]uridine incorporations, into DHAQ treated cells indicated that DHAQ prevented the accumulation of radioactivity into the nuclei in a concentration dependent manner. These results gave further indication that mitoxantrone induced a definitive alteration of nuclear template activities, correlated with nuclear functional-structural relation and suggested that the nucleoli were the primary site of DHAQ action.
已研究了米托蒽醌(DHAQ)对指数生长的人乳腺癌细胞系MDA - MB - 231掺入[3H]胸腺嘧啶核苷和[3H]尿嘧啶核苷的影响。结果表明,DHAQ以浓度依赖的方式抑制[3H]胸腺嘧啶核苷掺入比抑制[3H]尿嘧啶核苷掺入更有效。在20 ng/ml浓度的药物处理后,观察到生长和[3H]胸腺嘧啶核苷掺入有50%的抑制,而[3H]尿嘧啶核苷掺入仅被抑制约12%。在2000 ng/ml的DHAQ时,细胞生长、[3H]胸腺嘧啶核苷和[3H]尿嘧啶核苷掺入的抑制率分别为78%、95%和62%。在DHAQ处理的细胞中,[3H]胸腺嘧啶核苷和[3H]尿嘧啶核苷掺入后,在光镜和电镜放射自显影水平检测到的核相关放射性表明,DHAQ以浓度依赖的方式阻止放射性在细胞核中的积累。这些结果进一步表明米托蒽醌诱导了核模板活性的明确改变,与核功能 - 结构关系相关,并表明核仁是DHAQ作用的主要部位。